Safety and Efficacy Evaluation of Mouth Wash(Glister Mouth Wash): Pilot Study
Launched by WONJU SEVERANCE CHRISTIAN HOSPITAL · Nov 30, 2022
Trial Information
Current as of May 21, 2025
Completed
Keywords
ClinConnect Summary
2.1. Participants In all, 100 subjects were recruited to this clinical study according to the following inclusion criteria: i) Healthy male or female; ii) presence of \>20 existing teeth (the number of remaining teeth); iii) no severe pathological soft tissue conditions, periodontitis, or extensive dental plaque; iv) Turesky modification of the Quigley-Hein Plaque Index (PI) of over 1.5 and Loe \& Silness Gingival Index (GI) of over 1.5; vi) able to perform oral care/hygiene tasks on his/her own; vii) voluntary participation; and viii) willing to comply with the test protocol. Participants ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy male or female;
- • presence of \>20 existing teeth (the number of remaining teeth);
- • no severe pathological soft tissue conditions, periodontitis, or extensive dental plaque;
- • Turesky modification of the Quigley-Hein Plaque Index (PI) of over 1.5 and Loe \& Silness Gingival Index (GI) of over 1.5; • able to perform oral care/hygiene tasks on his/her own;
- • voluntary participation; and viii) willing to comply with the test protocol.
- Exclusion Criteria:
- • They excluded if they had any kind of visible or known disease requiring prophylactic antibiotic use.
About Wonju Severance Christian Hospital
Wonju Severance Christian Hospital is a leading healthcare institution based in South Korea, renowned for its commitment to innovative medical research and high-quality patient care. As a prominent clinical trial sponsor, the hospital is dedicated to advancing medical knowledge through rigorous scientific studies and trials across various therapeutic areas. With a multidisciplinary team of experienced researchers and healthcare professionals, Wonju Severance Christian Hospital strives to improve treatment outcomes and enhance the overall health and well-being of patients. Its state-of-the-art facilities and adherence to ethical standards ensure a robust framework for conducting clinical research that meets both local and international regulatory requirements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Wonju, Ganwon Do, Korea, Republic Of
Patients applied
Trial Officials
Kyu-Jae Lee, Ph.D.
Study Chair
Wonju College of Medicine, Yonsei University, Republic of Korea
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials